Home > Share Market > Stocks > Nectar lifescience > Financial Statements > NECLIFE Key Financial Ratios

Nectar lifescience Financial Statements

Nectar lifescience Key Financial Ratios

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth (35) 26.10 14.10 (1.90)
Op profit growth (50) (7) 5.23 (6)
EBIT growth (68) (8.20) (3.80) (1.20)
Net profit growth (330) (39) (5.50) 2.02
Profitability ratios (%)        
OPM 7.07 9.28 12.60 13.70
EBIT margin 3.41 6.90 9.48 11.20
Net profit margin (4.70) 1.34 2.79 3.37
RoCE 2.54 7.83 8.64 9.25
RoNW (1.70) 0.72 1.27 1.41
RoA (0.90) 0.38 0.63 0.69
Per share ratios ()        
EPS (3.30) 1.42 2.33 2.47
Dividend per share -- 0.05 0.05 0.05
Cash EPS (6) (1.30) (0.50) (0.30)
Book value per share 47.40 50.70 47.20 44.90
Valuation ratios        
P/E (5.70) 6.96 11.40 14.30
P/CEPS (3.10) (7.70) (49) (114)
P/B 0.39 0.20 0.56 0.78
EV/EBIDTA 11.50 4.37 6.35 6.70
Payout (%)        
Dividend payout -- -- 2.15 2.03
Tax payout (19) (15) (17) (18)
Liquidity ratios        
Debtor days 91.10 77.70 108 110
Inventory days 185 142 167 188
Creditor days (122) (94) (119) (132)
Leverage ratios        
Interest coverage (0.50) (1.30) (1.50) (1.60)
Net debt / equity 0.83 0.67 0.89 0.86
Net debt / op. profit 8.05 3.45 4 3.85
Cost breakup ()        
Material costs (75) (79) (73) (70)
Employee costs (4.80) (3.40) (4.20) (4.80)
Other costs (13) (8.80) (10) (11)

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000